Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin. - Wikidata - wikimedia - TriplyDB

Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.

Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.

http://www.wikidata.org/entity/Q39854715

about

Ceftriaxone therapy of serious bacterial infections in adults.Pharmacokinetics of ceftriaxone in patients with typhoid fever Enhanced antibacterial effect of ceftriaxone sodium-loaded chitosan nanoparticles against intracellular Salmonella typhimurium.Pharmacokinetics of a new, orally available ceftriaxone formulation in physical complexation with a cationic analogue of bile acid in rats.Daily variations in ceftriaxone pharmacokinetics in rats Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamase.Comparative in vitro activity of ceftibuten (Sch 39720) against bacterial enteropathogens.Single-dose ceftriaxone versus multiple-dose trimethoprim-sulfamethoxazole in the treatment of acute urinary tract infections Comparative efficacy of ciprofloxacin and ceftriaxone in experimental arthritis caused by Escherichia coli Synergistic activities of combinations of beta-lactams, fosfomycin, and tobramycin against Pseudomonas aeruginosa Gall-bladder sludge: lessons from ceftriaxone.Dose-ranging study of ceftriaxone for uncomplicated gonorrhea in men.Single-dose pharmacokinetics of ceftriaxone in infants and young children.Activities of eight new beta-lactam antibiotics and seven antibiotic combinations against Neisseria meningitidis.Comparative activities of 13 beta-lactam antibiotics Ceftriaxone: in vitro studies and clinical evaluation Ceftriaxone (Ro 13-9904) therapy of serious infection.Comparative efficacies of ceftriaxone, moxalactam, and ampicillin in experimental Salmonella typhimurium infection Differences in susceptibilities of species of the Bacteroides fragilis group to several beta-lactam antibiotics: indole production as an indicator of resistance.Ceftriaxone diffusion into cerebrospinal fluid of children with meningitis.In vitro antimicrobial activity of eight new beta-lactam antibiotics against penicillin-resistant Neisseria gonorrhoeae Clinical pharmacology of ceftriaxone in patients with neoplastic disease.Ceftriaxone therapy of bone and soft tissue infections in hospital and outpatient settings.Pharmacokinetics of ceftriaxone in patients with renal failure and in those undergoing hemodialysis Ceftriaxone levels in blood and tissue during cardiopulmonary bypass surgery.Kinetic disposition of intravenous ceftriaxone in normal subjects and patients with renal failure on hemodialysis or peritoneal dialysis Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment Comparative study of ceftriaxone and aqueous procaine penicillin G in the treatment of uncomplicated gonorrhea in women.Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans.Treatment of typhoid fever with ceftriaxone for 5 days or chloramphenicol for 14 days: a randomized clinical trial Interleukin-6, gamma interferon, and tumor necrosis factor receptors in typhoid fever related to outcome of antimicrobial therapy Synergistic protective role of ceftriaxone and ascorbic acid against subacute diazinon-induced nephrotoxicity in rats Use of third-generation cephalosporins. Pseudomonas.Use of third-generation cephalosporins. Enterobacteriaceae.Influence of temperature on degradation kinetics of ceftriaxone in diluted and undiluted human serum.Once-daily ceftriaxone therapy for serious bacterial infections in children.Antimicrobial susceptibilities of Listeria monocytogenes strains isolated from 1958 to 1982 in Sweden.Ceftriaxone: a beta-lactamase-stable, broad-spectrum cephalosporin with an extended half-life.Once-daily ceftriaxone for skin and soft tissue infections.Comparative efficacies of single intravenous doses of ceftriaxone and ampicillin for shigellosis in a placebo-controlled trial.

P2860

Q33476936-23AAC7E6-BF4B-4E68-9D08-AB3055503DA2 Q33761560-053B3FBD-ED46-4B81-A9B1-72A0DF0A78DC Q34167667-D67295DB-47D3-42BE-B54B-9EB395FDD0BB Q34648762-9DA792BC-2BA5-4089-B3DB-69C38C697817 Q34824282-FCFFA8FB-5E59-4C05-AF90-37868BE3ADE4 Q35280038-405CCD44-BB9B-4478-9A13-8CC27BB70B9A Q35334786-363DD5F5-7189-4E05-AB5A-1BFD70207144 Q35569392-3BF43FDA-5742-4759-9914-4A1EDB464B79 Q35574677-ED3DAA6A-CD2B-47E2-827E-E40238645168 Q35640792-7768D23B-1177-4AB4-8628-EB3BBCC2B9D9 Q35659918-1C810AB7-A918-4D35-AE17-6F046F413CBE Q35672864-D193E4C2-D4BD-46CB-9680-E68A2CE06E0F Q35673633-A356ABEB-7DA9-49CF-8B37-421E160DFD13 Q35675331-1A232B93-F379-4CC4-A095-913C81DDAC83 Q35676188-18EA4CE0-93FB-43EF-AD52-F036D7497240 Q35712352-2F61D65C-A1D3-4C04-8FD9-648A4139001C Q35712560-DECF1800-0CCA-4FB5-B0A8-91CB50DA8F68 Q35715192-44AE5D3C-C905-494D-A850-FFEF194C9C9A Q35718303-D670ED19-4700-4E78-930F-10A2C065EF9D Q35739719-D0FEBEF9-43F6-4A0F-B290-489A3C5B1F10 Q35740391-D38BCE1C-987A-4F93-B38D-178DCE7382E3 Q35740465-4F9D29CA-F622-4EB6-9C68-A6075BA32F9D Q35742444-A26B3923-6F32-4FD7-8297-43873FC7FED3 Q35755052-9C8B79ED-5704-4ACB-93EE-2BCDB5503729 Q35756133-1B367EA1-7BFC-4628-AB2C-E34F97DDCEF8 Q35756292-85D9B053-8528-4BF2-BA47-38A2179FA9CC Q35758837-248905CB-E953-441E-9CB8-C41DFE603109 Q35769451-DFAF3890-5235-466F-A1F4-5F549B1E65F6 Q35807561-C42970CA-2E64-4EF7-8EF1-EEA3C6092077 Q35817567-8CDB52FA-435B-4C73-A2C6-81257C5341D5 Q35900104-75BEBB44-667A-4E24-B002-7BFB8A32940B Q36582030-F7A9C9AF-24AF-4E68-A9DB-5C62986C61D4 Q37381368-1878436B-3E5C-4D04-B964-5B2194A64FF8 Q37381380-59852815-C4D4-4666-B4AF-65580C95C70C Q39816333-C8E92C25-DA7C-4CAD-807D-04B020A3FFE5 Q39833765-8F13EAD4-9107-4920-9BD3-B1078148DE72 Q39834031-8EA5EA0B-4654-4289-885E-7B00CC5FB641 Q39835731-B77B2C3D-52DE-4AB5-9875-EC88CCC642A7 Q39849744-85B3DF30-3626-45A9-8166-1657C759646C Q39851112-B45BD789-F939-41B0-858B-4B50B2886B68

P2860

Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.

http://www.wikidata.org/entity/Q39854715

description

1981 nî lūn-bûn

@nan

1981年の論文

@ja

1981年学术文章

@wuu

1981年学术文章

@zh-cn

1981年学术文章

@zh-hans

1981年学术文章

@zh-my

1981年学术文章

@zh-sg

1981年學術文章

@yue

1981年學術文章

@zh

1981年學術文章

@zh-hant

name

Antibacterial activity of ceft ...... actamase-stable cephalosporin.

@en

Antibacterial activity of ceft ...... actamase-stable cephalosporin.

@nl

type

label

Antibacterial activity of ceft ...... actamase-stable cephalosporin.

@en

Antibacterial activity of ceft ...... actamase-stable cephalosporin.

@nl

prefLabel

Antibacterial activity of ceft ...... actamase-stable cephalosporin.

@en

Antibacterial activity of ceft ...... actamase-stable cephalosporin.

@nl

P1433

Q39854715-49DF2890-A721-4C7A-82AD-DC64F8EACFE9

P1476

Q39854715-92F4ACDC-D21B-4D14-AFAD-2CFC1B53FC1C

P2093

Q39854715-119B5662-EBF4-413D-878A-70AF7A998D83

Q39854715-F880EA02-4E47-4F4E-9B4A-827A54384201

Q39854715-FA098A11-100F-4D39-9DCA-F1F36EFD6583

P2860

Q39854715-45BB7589-AA0D-4E9D-81FC-B4ECEB80BB31

Q39854715-6C7A61D5-F587-4FA5-813B-AFA80968AA20

Q39854715-8C174904-5E31-4A72-87D4-1B91316270DE

Q39854715-B41825C6-645B-40AB-BC65-08265711C54C

Q39854715-BB551D7A-6282-418A-AEAF-1848A56F7586

Q39854715-DFB03F07-AA7E-49AF-A518-2342EC379341

Q39854715-F9393CBF-003C-4BA1-B38C-58AB90C6E5AA

Q39854715-FE7ABB4E-9814-467E-8586-52151074C715

P304

Q39854715-D022D030-DB54-43F0-BAD5-B1DB4D4CD4A7

P31

Q39854715-828CDF26-E405-44AC-B9C4-10166D77CA85

P356

Q39854715-D3B03266-5D97-4462-B159-C9D783797AB9

P407

Q39854715-4330E1F7-AA7D-4CC1-AB5E-34544CC1A3AA

P433

Q39854715-AB83DB9B-0D3B-452A-8DFA-D127EA235D9B

P478

Q39854715-4666741E-62A5-4FAB-A20D-C84F1A7AB154

P577

Q39854715-C1088263-3B66-4177-AACD-951255517E1F

P698

Q39854715-C5FC2A77-1078-4BDF-A6EC-057E9CF1CF8C

P932

Q39854715-B030471F-6902-4B7F-8D2E-16BEE3ACE641

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Antibacterial activity of ceft ...... actamase-stable cephalosporin.

@en

P2093

Fu KP

http://www.w3.org/2001/XMLSchema#string

Meropol NJ

http://www.w3.org/2001/XMLSchema#string

Neu HC

http://www.w3.org/2001/XMLSchema#string

P2860

Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate

Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity.

Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin.

HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria.

Antibacterial activity of a new 1-oxa cephalosporin compared with that of other beta-lactam compounds.

Comparative activity and beta-lactamase stability of cefoperazone, a piperazine cephalosporin.

Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases.

Studies on gonococcus infection. XI. Comparison of in vivo and vitro association of Neisseria gonorrhoeae with human neutrophils.

P304

414-423

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.19.3.414

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

1981-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

6972729

http://www.w3.org/2001/XMLSchema#string

P932

181447

http://www.w3.org/2001/XMLSchema#string